Association of beta‐hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of beta‐hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-08
DOI
10.1111/eci.13468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy
- (2020) Jiang-Ping Song et al. Science Translational Medicine
- Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance Index
- (2020) Erwin Garcia et al. Journal of Clinical Medicine
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial adipose deposition and the development of heart failure with preserved ejection fraction
- (2019) Cho‐Kai Wu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension
- (2019) Jose L. Flores-Guerrero et al. HYPERTENSION
- Relationships between circulating branched chain amino acid concentrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI
- (2018) Xiaoyu Du et al. Scientific Reports
- Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling
- (2018) Gabor Voros et al. Circulation-Heart Failure
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Heart Failure with Preserved Ejection Fraction in Women
- (2018) Anjan Tibrewala et al. Heart Failure Clinics
- The diabetic heart utilizes ketone bodies as an energy source
- (2017) Yuji Mizuno et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
- (2017) Masaru Obokata et al. Journal of the American Heart Association
- Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
- (2017) Setor K. Kunutsor et al. Journal of the American Heart Association
- Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
- (2016) Kenneth C. Bedi et al. CIRCULATION
- The Failing Heart Relies on Ketone Bodies as a Fuel
- (2016) Gregory Aubert et al. CIRCULATION
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study
- (2015) Setor K. Kunutsor et al. ATHEROSCLEROSIS
- Clinical Risk Stratification Optimizes Value of Biomarkers to Predict New-Onset Heart Failure in a Community-Based Cohort
- (2014) Frank P. Brouwers et al. Circulation-Heart Failure
- Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
- (2014) Rebecca C. Schugar et al. Molecular Metabolism
- The SLC16 gene family – Structure, role and regulation in health and disease
- (2013) Andrew P. Halestrap MOLECULAR ASPECTS OF MEDICINE
- Exhaled Acetone as a New Biomarker of Heart Failure Severity
- (2012) Fabiana G. Marcondes-Braga et al. CHEST
- Heart Failure in Women
- (2012) J. Julia Shin et al. CLINICAL CARDIOLOGY
- Age and sex affect protein metabolism at protein intakes that span the range of adequacy: comparison of leucine kinetics and nitrogen balance data
- (2012) Travis B. Conley et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
- (2012) James P. Corsetti et al. PLoS One
- High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol
- (2009) Robin P.F. Dullaart et al. ATHEROSCLEROSIS
- A catalogue of reporting guidelines for health research
- (2009) I. Simera et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started